Skip to content

Joshua David Lee, MD

NPI 1114132701ActiveIndividual· Internal Medicine, Addiction Medicine· New York, NY

Internal Medicine, Addiction Medicine (MD) in New York, New York, licensed in NY, with an NPI issued in May 2007. Part D covered 89 prescriptions written in 2024, 84% of them generic. Actelion Pharmaceuticals US, Inc. was the largest of 7 companies reporting payments in 2025, $385.93 in all, mostly food and beverage.

Overview

NPI1114132701
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMay 14, 2007
Last updated in NPPESNov 22, 2024
Certified by providerNov 21, 2024

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Addiction Medicine Primary207RA0401X220463NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Addiction Medicine (NY)

Part D prescriptions in 2024

Prescriptions (claims)89 · 109 30-day fills
Patients13
Total drug cost$17,499
Generic share84% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$385.93 · 24 payments from 7 companies
  • 2024$353.88 · 18 payments from 5 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$385.93 · 24 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Addiction Medicine providers in New York

All 15 Internal Medicine, Addiction Medicine providers in New York · All Internal Medicine, Addiction Medicine providers in New York